Ratio Therapeutics Scores $50M Series B - VC News Daily
Ratio Therapeutics Inc. (Ratio), a pharmaceutical company that employs a suite of innovative technologies to develop best-in-class radiopharmaceuticals for the treatment and monitoring of …
OFF
Ratio Therapeutics Scores $50M Series B - VC News Daily
6 days from now
Ratio Therapeutics Inc. (Ratio), a pharmaceutical company that employs a suite of innovative technologies to develop best-in-class radiopharmaceuticals for the treatment and monitoring of …
vcnewsdaily.com
OFF
Media - Ratio Therapeutics
6 days from now
Oct 23, 2024 · Ratio Therapeutics Scores $50M Series B. VC News Daily | January 17th, 2024. Ratio Therapeutics announces the close of its $50M Series B financing. Read More. Boston’s …
ratiotx.com
OFF
January 17th, 2024: Ratio Therapeutics Announces $50M Series B ...
6 days from now
Jan 17, 2024 · Boston-Based Radiopharmaceutical Company Brings Total Financing to More Than $90Million Since 2021 Launch. BOSTON, January 17, 2024 – Ratio Therapeutics Inc. …
ratiotx.com
OFF
Ratio Therapeutics Announces $50M Series B Financing To …
6 days from now
Ratio Therapeutics Inc. (Ratio), a pharmaceutical company that employs a suite of innovative technologies to develop best-in-class radiopharmaceuticals for the treatment and monitoring of …
yahoo.com
OFF
Ratio Therapeutics Raises $50M In Series B Financing
6 days from now
Jan 17, 2024 · In July 2023, Ratio began studying its FAP-targeted, Cu-64-labeled radiopharmaceutical, RTX-1363S, in a Phase I trial in healthy volunteers. According to a …
precisionmedicineonline.com
OFF
Series B - Ratio Therapeutics - 2024-01-17 - Crunchbase
6 days from now
Jan 17, 2024 · Ratio Therapeutics raised $50000000 on 2024-01-17 in Series B. January 17th, 2024: Ratio Therapeutics Announces $50M Series B Financing to Advance Targeted …
crunchbase.com
OFF
Ratio Therapeutics Announces $50M Series B Financing To …
6 days from now
Jan 17, 2024 · Boston-Based Radiopharmaceutical Company Brings Total Financing to More Than $90 Million Since 2021 Launch. BOSTON, MA, USA I January 17, 2024 I Ratio …
pipelinereview.com
OFF
Ratio Therapeutics - Recent News & Activity - Crunchbase
6 days from now
VC News Daily — Ratio Therapeutics Scores $50M Series B Funding Round • Jan 17, 2024 Ratio Therapeutics raised $50,000,000 / Series B from Bristol-Myers Squibb and 4 other investors
crunchbase.com
OFF
Ratio Therapeutics Announces $50M Series B Financing To …
6 days from now
BOSTON, Jan. 17, 2024 /PRNewswire/ -- Ratio Therapeutics Inc. (Ratio), a pharmaceutical company that employs a suite of innovative technologies to develop best-in-class …
biospace.com
OFF
Ratio Therapeutics Raises $50M For Tumor-targeting …
6 days from now
Jan 17, 2024 · Ratio announced its $50M Series B financing Wednesday. Investors in this round of capital included Series A leads Duquesne Capital and Schusterman Family Investments, as …
bizjournals.com
OFF
Series B - Ratio Therapeutics - 2024-01-17 - Recent News
6 days from now
Ratio Therapeutics raised $50000000 on 2024-01-17 in Series B. Fierce Pharma — BMS-backed radiopharma specialist Ratio expands manufacturing deal with CDMO PharmaLogic
crunchbase.com
OFF
Ratio Therapeutics Scores $50M Series B | AlphaMaven
6 days from now
BOSTON, MA, Ratio Therapeutics announces the close of its $50M Series B financing. - #venture-capital #AlphaMaven. Alpha Maven Alpha Maven. Investment Listings ... Top …
alpha-maven.com
OFF
Ratio Therapeutics Announces $50M Series B Financing To …
6 days from now
BOSTON, January 17, 2024-- Ratio Therapeutics Inc. (Ratio), a pharmaceutical company that employs a suite of innovative technologies to develop best-in-class radiopharmaceuticals for …
vcaonline.com
OFF
Ratio Raises $50M As Radiopharma Field Finds Its Groove
6 days from now
Jan 17, 2024 · Radiopharmaceutical biotech Ratio Therapeutics has raised a $50 million Series B to bring its first therapeutic into the clinic, it said Wednesday morning. ... ENDPOINTS NEWS …
endpts.com
OFF
Novartis Strengthens Radiopharma Leadership With Ratio …
6 days from now
3 days ago · Novartis has teamed up with Ratio Therapeutics in a $745m licensing and collaboration agreement to advance radiopharmaceutical therapies.
yahoo.com
OFF
OncoMyx Closes $50M Series B - VC News Daily
6 days from now
Dec 8, 2021 · PHOENIX, AZ, OncoMyx Therapeutics, a privately-held immuno-oncology platform company, announced the closing of a $50 million Series B financing. ... ARCHIVE; ABOUT …
vcnewsdaily.com
FAQs about Ratio Therapeutics Scores $50M Series B - VC News Daily Coupon?
Who backed ratio's $50M Series B financing?
Will ratio Therapeutics move its first drug candidate into clinical trials?
What is Novartis partnering with ratio Therapeutics?
What is ratio & how does it work?
How much money will Novartis get from ratio?
Install CouponFollow Extension on Chrome
Install the CouponFollow extension to search for discount codes when shopping the fastest!
Install CouponFollow Chrome Extension
Listing Store by Characters
